Ablexis, LLC
Ablexis, LLC, a pioneering biotechnology company headquartered in the United States, has been at the forefront of antibody discovery since its establishment in 2010. With a strong operational presence across North America and Europe, Ablexis focuses on developing innovative solutions for therapeutic antibody generation, utilising its proprietary AlivaMab® platform. The company’s core offerings include the AlivaMab platform, which enables the rapid and efficient creation of fully human monoclonal antibodies. This unique technology streamlines the drug development process, significantly reducing time and costs for clients in the pharmaceutical and biotechnology sectors. Recognised for its contributions to the industry, Ablexis has established a solid market position, collaborating with leading biopharmaceutical companies to advance therapeutic options for various diseases. With a commitment to innovation and excellence, Ablexis continues to shape the future of antibody therapeutics.
DitchCarbon Score
How does Ablexis, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ablexis, LLC's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ablexis, LLC's reported carbon emissions
Ablexis, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Ablexis may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, it is unclear how Ablexis aligns with broader climate action goals within its industry. Without emissions data or reduction initiatives, the company's climate commitments remain unspecified, highlighting a potential area for future development in sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ablexis, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
